{"id":"https://openalex.org/W7225309757","doi":"https://doi.org/10.3389/fimmu.2026.1973237","title":"Biologic dose reduction versus standard dosing in psoriasis: what is lost and what is gained?","display_name":"Biologic dose reduction versus standard dosing in psoriasis: what is lost and what is gained?","publication_year":2026,"publication_date":"2026-11-05","ids":{"openalex":"https://openalex.org/W7225309757","doi":"https://doi.org/10.3389/fimmu.2026.1973237"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1973237","doi":"https://doi.org/10.3389/fimmu.2026.1973237","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1973237","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1973237/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1973237/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026105189","display_name":"Xiya Peng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiya Peng","raw_affiliation_strings":["Department of Dermatology & Venerology, Rare Diseases Center, West China Hospital, Sichuan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology & Venerology, Rare Diseases Center, West China Hospital, Sichuan University","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101875878","display_name":"Xueqin Xu","orcid":"https://orcid.org/0000-0002-9814-4517","observed_orcids":["https://orcid.org/0000-0002-9814-4517"]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xueqin Xu","raw_affiliation_strings":["Department of Dermatology & Venerology, Gaoxin Hospital, Affiliated To West China Second School Of Medicine, Sichuan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology & Venerology, Gaoxin Hospital, Affiliated To West China Second School Of Medicine, Sichuan University","institution_ids":["https://openalex.org/I24185976"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085021539","display_name":"\u97e9\u6606","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113011","display_name":"Weifang People's Hospital","ror":"https://ror.org/01xd2tj29","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210113011"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Kun Han","raw_affiliation_strings":["Department of Nuclear Medicine, Weifang People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Weifang People\u2019s Hospital","institution_ids":["https://openalex.org/I4210113011"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160955606","display_name":"Yu Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113011","display_name":"Weifang People's Hospital","ror":"https://ror.org/01xd2tj29","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210113011"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yu Sun","raw_affiliation_strings":["Department of Anesthesiology, Weifang People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology, Weifang People\u2019s Hospital","institution_ids":["https://openalex.org/I4210113011"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5085021539","https://openalex.org/A5160955606"],"corresponding_institution_ids":["https://openalex.org/I4210113011"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8389999866485596},{"id":"https://openalex.org/keywords/standard-dosing","display_name":"standard dosing","score":0.7860000133514404},{"id":"https://openalex.org/keywords/pasi-90","display_name":"PASI 90","score":0.7940000295639038},{"id":"https://openalex.org/keywords/pasi-100","display_name":"PASI 100","score":0.9890000224113464},{"id":"https://openalex.org/keywords/disease-flares","display_name":"disease flares","score":0.8009999990463257},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.5519999861717224},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9330000281333923},{"id":"https://openalex.org/keywords/biologic-safety","display_name":"biologic safety","score":0.7110000252723694},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.9032999873161316},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8751000165939331},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7595999836921692},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6299999952316284},{"id":"https://openalex.org/C111335779","wikidata":"https://www.wikidata.org/wiki/Q3454686","display_name":"Reduction (mathematics)","level":2,"score":0.5277000069618225},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.47859999537467957},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4726000130176544},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.4496000111103058},{"id":"https://openalex.org/C2993769353","wikidata":"https://www.wikidata.org/wiki/Q7598360","display_name":"Standard of care","level":2,"score":0.439300000667572},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.39890000224113464},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35899999737739563},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.35839998722076416},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3188999891281128},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3158999979496002},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.3154999911785126},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.31029999256134033},{"id":"https://openalex.org/C27924281","wikidata":"https://www.wikidata.org/wiki/Q17126475","display_name":"Maintenance dose","level":2,"score":0.2896000146865845},{"id":"https://openalex.org/C2988170871","wikidata":"https://www.wikidata.org/wiki/Q11000047","display_name":"Healthcare system","level":3,"score":0.2766999900341034},{"id":"https://openalex.org/C2911221801","wikidata":"https://www.wikidata.org/wiki/Q2742406","display_name":"Biologic Agents","level":3,"score":0.2542000114917755}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fimmu.2026.1973237","doi":"https://doi.org/10.3389/fimmu.2026.1973237","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1973237","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1973237/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:c3d6a4930b6248c38ba5ee1bdd1d9243","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c3d6a4930b6248c38ba5ee1bdd1d9243","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1973237","doi":"https://doi.org/10.3389/fimmu.2026.1973237","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1973237","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1973237/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225309757.pdf","grobid_xml":"https://content.openalex.org/works/W7225309757.grobid-xml"},"referenced_works_count":60,"referenced_works":["https://openalex.org/W1488772574","https://openalex.org/W1932535307","https://openalex.org/W1969991375","https://openalex.org/W1981177225","https://openalex.org/W2003059802","https://openalex.org/W2019714802","https://openalex.org/W2033978760","https://openalex.org/W2103018315","https://openalex.org/W2108987697","https://openalex.org/W2623211590","https://openalex.org/W2789815934","https://openalex.org/W2800010837","https://openalex.org/W2945527657","https://openalex.org/W3005392748","https://openalex.org/W3006361551","https://openalex.org/W3028355101","https://openalex.org/W3048022379","https://openalex.org/W3103233798","https://openalex.org/W3117231578","https://openalex.org/W3123517269","https://openalex.org/W3124008657","https://openalex.org/W3157853460","https://openalex.org/W3165381022","https://openalex.org/W3196327689","https://openalex.org/W4200171094","https://openalex.org/W4206469967","https://openalex.org/W4206739528","https://openalex.org/W4220984603","https://openalex.org/W4281290093","https://openalex.org/W4294032315","https://openalex.org/W4294917547","https://openalex.org/W4308285433","https://openalex.org/W4308916009","https://openalex.org/W4311501432","https://openalex.org/W4315471333","https://openalex.org/W4321482942","https://openalex.org/W4323308435","https://openalex.org/W4383058635","https://openalex.org/W4386221007","https://openalex.org/W4386979770","https://openalex.org/W4388042291","https://openalex.org/W4389149791","https://openalex.org/W4390542832","https://openalex.org/W4391249050","https://openalex.org/W4392888170","https://openalex.org/W4393276317","https://openalex.org/W4400102092","https://openalex.org/W4401170382","https://openalex.org/W4407614967","https://openalex.org/W4410117200","https://openalex.org/W4410381987","https://openalex.org/W4412827923","https://openalex.org/W4414152816","https://openalex.org/W4416077836","https://openalex.org/W4416586392","https://openalex.org/W7155052755","https://openalex.org/W7162636038","https://openalex.org/W7163021466","https://openalex.org/W7169665823","https://openalex.org/W7172024672"],"related_works":["https://openalex.org/W1917666393","https://openalex.org/W2613958818","https://openalex.org/W4321482942","https://openalex.org/W4403924693","https://openalex.org/W4385684691","https://openalex.org/W2014151562","https://openalex.org/W3006361551","https://openalex.org/W7201837657","https://openalex.org/W7155661030","https://openalex.org/W3123517269"],"abstract_inverted_index":{"As":[0],"increasing":[1],"numbers":[2],"of":[3,40,50,55,70,142,167],"patients":[4,108],"with":[5,161],"psoriasis":[6,181],"achieve":[7],"stable":[8],"disease":[9,51,91],"control,":[10,52],"biologic":[11,41,132],"dose":[12,42,64,110,151],"reduction":[13,43,65,152],"has":[14],"become":[15],"an":[16],"important":[17],"question":[18],"in":[19,48,140],"maintenance":[20,94],"treatment.":[21,95,188],"This":[22,176],"narrative":[23],"review":[24],"synthesizes":[25],"evidence":[26,61],"from":[27],"randomized":[28],"controlled":[29],"trials":[30],"and":[31,38,57,78,83,86,90,134,173,186],"observational":[32],"studies":[33],"to":[34],"compare":[35],"the":[36,68,118,165],"losses":[37],"gains":[39,129],"versus":[44],"continued":[45],"standard":[46,122],"dosing":[47,123],"terms":[49],"safety,":[53],"quality":[54,141],"life,":[56],"healthcare":[58],"costs.":[59],"Current":[60],"suggests":[62],"that":[63,117],"may":[66,102,177],"reduce":[67],"rates":[69],"high-level":[71],"skin":[72],"clearance,":[73],"such":[74],"as":[75],"Psoriasis":[76],"Area":[77],"Severity":[79],"Index":[80],"(PASI)":[81],"90":[82],"PASI":[84],"100,":[85],"increase":[87],"transient":[88],"flares":[89],"fluctuations":[92],"during":[93],"By":[96],"contrast,":[97],"broader":[98],"PASI-based":[99],"response":[100,119],"criteria":[101],"still":[103],"be":[104,155],"met":[105],"by":[106,164],"many":[107],"after":[109],"reduction,":[111],"but":[112],"this":[113],"does":[114],"not":[115,147],"mean":[116],"achieved":[120],"under":[121],"was":[124],"fully":[125],"preserved.":[126],"The":[127],"clearest":[128],"were":[130],"lower":[131],"use":[133],"short-term":[135],"treatment":[136,171],"costs,":[137],"while":[138],"improvements":[139],"life":[143],"or":[144],"safety":[145],"have":[146],"been":[148],"demonstrated.":[149],"Biologic":[150],"should":[153],"therefore":[154],"considered":[156],"a":[157],"cautious,":[158],"individualized":[159],"strategy,":[160],"decisions":[162],"informed":[163],"magnitude":[166],"any":[168],"efficacy":[169],"loss,":[170],"burden,":[172],"patient":[174],"preferences.":[175],"help":[178],"move":[179],"long-term":[180],"management":[182],"toward":[183],"more":[184],"precise":[185],"personalized":[187]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-06T00:00:00"}